NCT04480190 2022-04-20Neoadjuvant Therapy in Biliary AdenocarcinomaUniversity of CincinnatiPhase 1 Withdrawn
NCT00386516 2017-08-01Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerGalectin Therapeutics Inc.Phase 2 Withdrawn